FDA Approves Beech Tree Labs, Inc.'s Oral Herpes IND Application

Published: Jul 07, 2010

PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc., announced today that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections. The study will be a 210 patient, multi-site, placebo-controlled trial and is anticipated to begin later this summer.

Back to news